Global Drug Eluting Balloon Market: Industry Analysis and Forecast (2019-2026) – by Product Type, Technology, End-user, and Region.

Global Drug Eluting Balloon Market was valued US$ XX Mn in 2018 and is expected to reach US$ XX Mn by 2026, at CAGR of XX% during forecast period. To know about the Research Methodology:-Request Free Sample Report Drug Eluting Balloons (DEB) are conventional semi-compliant angioplasty balloons coated with an anti-proliferative drug, which is released into vessel wall during inflation of the balloon, generally at nominal pressures with a precise minimal inflation time. Drug eluting balloon plays an important role in modern healthcare, as it delivers medication and prevents neointimal hyperplasia. Increasing occurrence of coronary artery diseases among people across the globe is a key factor expected to drive the growth of the global drug eluting balloon market over the forecast period. According to the World Health Organization (WHO), about 17.9 Mn people die, every year caused by coronary heart disease across the globe. Besides, increasing the prevalence of diabetes is another factor expected to further fuel the growth of the drug eluting balloon market over the forecast period. For instance, according to WHO, in October 2018 reported over 1.6 Mn deaths are registered, which are caused by diabetes across globe. Furthermore, rising manufacturer’s inclination towards acquisition strategies to develop innovative products and expand their product portfolio is another factor expected to boost the growth of the drug eluting balloon market over the forecast period. Also, the presence of major players operating in the drug eluting balloon market, such as Medtronic, Inc. and Boston Scientific Corporation and increasing R&D activities for drug eluting balloon is another factor, expected to boost the growth of the drug eluting balloon market in a certain extent. However, adverse effects such as lumen enlargement and coronary artery lesions are expected to restrain the growth of the global drug eluting balloon market over the forecast period. For instance, in May 2017, Abbott Laboratory recalled three balloon catheters due to problems faced while removing balloon sheath, which caused 19 incidences of injury and 1 death. According to the product type segments, the peripheral drug eluting balloon segment is expected to dominate in the drug eluting balloon market in terms of revenue over the forecast period, also on account of increasing use of drug eluting balloon for treatment of peripheral artery diseases. Region-wise, the drug eluting balloon market in North America is expected to leading in the global drug eluting balloon market in terms of revenue over the forecast period, thanks to the increasing prevalence of cardiovascular diseases and obesity across several countries in the region over the forecast period. The objective of the report is to present a comprehensive analysis of the Global Drug Eluting Balloon Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants by Application. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by Application on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Drug Eluting Balloon Market dynamics, structure by analyzing the market segments and project the Global Drug Eluting Balloon Market size. Clear representation of competitive analysis of key players by Type, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Drug Eluting Balloon Market make the report investor’s guide. The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

Scope of the Global Drug Eluting Balloon Market: Inquire before buying

Global Drug Eluting Balloon Market, By Product Type

• Coronary Drug Eluting Balloon • Peripheral Drug Eluting Balloon • Others

Global Drug Eluting Balloon Market, By Technology

• Paccocath • FreePac • TransPax • EnduraCoat • Others

Global Drug Eluting Balloon Market, By End-user

• Hospitals & Ambulatory Surgery Centers • CATH Laboratories • Others

Global Drug Eluting Balloon Market, By Region

• North America • Europe • Asia Pacific • Middle East and Africa • South America

Key players operating in Global Drug Eluting Balloon Market

• Medtronic, Inc. • Becton, Dickinson and Company • Boston Scientific Corporation • Cook Medical Incorporated • Braun Melsungen AG • Koninklijke Philips N.V. • Opto Circuits (India) Limited • Terumo Corporation • Surmodics, Inc. • Biotronik, Inc. • Concept Medical Inc. • BIOTRONIK SE & Co. KG • Innvolution Healthcare Pvt. Ltd. • Medtronic plc • Eurocor GmbH • C.R. Bard • Aachen Resonance GmbH
Global Drug Eluting Balloon Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Drug Eluting Balloon Market, by Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Drug Eluting Balloon Market Analysis and Forecast 6.1. Global Drug Eluting Balloon Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Drug Eluting Balloon Market Analysis and Forecast, By Product Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Drug Eluting Balloon Market Value Share Analysis, By Product Type 7.4. Global Drug Eluting Balloon Market Size (US$ Mn) Forecast, By Product Type 7.5. Global Drug Eluting Balloon Market Analysis, By Product Type 7.6. Global Drug Eluting Balloon Market Attractiveness Analysis, By Product Type 8. Global Drug Eluting Balloon Market Analysis and Forecast, By Technology 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Drug Eluting Balloon Market Value Share Analysis, By Technology 8.4. Global Drug Eluting Balloon Market Size (US$ Mn) Forecast, By Technology 8.5. Global Drug Eluting Balloon Market Analysis, By Technology 8.6. Global Drug Eluting Balloon Market Attractiveness Analysis, By Technology 9. Global Drug Eluting Balloon Market Analysis and Forecast, By End-use 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Drug Eluting Balloon Market Value Share Analysis, By End-use 9.4. Global Drug Eluting Balloon Market Size (US$ Mn) Forecast, By End-use 9.5. Global Drug Eluting Balloon Market Analysis, By End-use 9.6. Global Drug Eluting Balloon Market Attractiveness Analysis, By End-use 10. Global Drug Eluting Balloon Market Analysis, by Region 10.1. Global Drug Eluting Balloon Market Value Share Analysis, by Region 10.2. Global Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Region 10.3. Global Drug Eluting Balloon Market Attractiveness Analysis, by Region 11. North America Drug Eluting Balloon Market Analysis 11.1. Key Findings 11.2. North America Drug Eluting Balloon Market Overview 11.3. North America Drug Eluting Balloon Market Value Share Analysis, By Product Type 11.4. North America Drug Eluting Balloon Market Forecast, By Product Type 11.4.1. Coronary Drug Eluting Balloon 11.4.2. Peripheral Drug Eluting Balloon 11.4.3. Others 11.5. North America Drug Eluting Balloon Market Value Share Analysis, By Technology 11.6. North America Drug Eluting Balloon Market Forecast, By Technology 11.6.1. Paccocath 11.6.2. FreePac 11.6.3. TransPax 11.6.4. EnduraCoat 11.6.5. Others 11.7. North America Drug Eluting Balloon Market Value Share Analysis, By End-use 11.8. North America Drug Eluting Balloon Market Forecast, By End-use 11.8.1. Hospitals & Ambulatory Surgery Centers 11.8.2. CATH Laboratories 11.8.3. Others 11.9. North America Drug Eluting Balloon Market Value Share Analysis, by Country 11.10. North America Drug Eluting Balloon Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Drug Eluting Balloon Market Analysis, by Country 11.12. U.S. Drug Eluting Balloon Market Forecast, By Product Type 11.12.1. Coronary Drug Eluting Balloon 11.12.2. Peripheral Drug Eluting Balloon 11.12.3. Others 11.13. U.S. Drug Eluting Balloon Market Forecast, By Technology 11.13.1. Paccocath 11.13.2. FreePac 11.13.3. TransPax 11.13.4. EnduraCoat 11.13.5. Others 11.14. U.S. Drug Eluting Balloon Market Forecast, By End-use 11.14.1. Hospitals & Ambulatory Surgery Centers 11.14.2. CATH Laboratories 11.14.3. Others 11.15. Canada Drug Eluting Balloon Market Forecast, By Product Type 11.15.1. Coronary Drug Eluting Balloon 11.15.2. Peripheral Drug Eluting Balloon 11.15.3. Others 11.16. Canada Drug Eluting Balloon Market Forecast, By Technology 11.16.1. Paccocath 11.16.2. FreePac 11.16.3. TransPax 11.16.4. EnduraCoat 11.16.5. Others 11.17. Canada Drug Eluting Balloon Market Forecast, By End-use 11.17.1. Hospitals & Ambulatory Surgery Centers 11.17.2. CATH Laboratories 11.17.3. Others 11.18. North America Drug Eluting Balloon Market Attractiveness Analysis 11.18.1. By Product Type 11.18.2. By Technology 11.18.3. By End-use 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Development 12. Europe Drug Eluting Balloon Market Analysis 12.1. Key Findings 12.2. Europe Drug Eluting Balloon Market Overview 12.3. Europe Drug Eluting Balloon Market Value Share Analysis, By Product Type 12.4. Europe Drug Eluting Balloon Market Forecast, By Product Type 12.4.1. Coronary Drug Eluting Balloon 12.4.2. Peripheral Drug Eluting Balloon 12.4.3. Others 12.5. Europe Drug Eluting Balloon Market Value Share Analysis, By Technology 12.6. Europe Drug Eluting Balloon Market Forecast, By Technology 12.6.1. Paccocath 12.6.2. FreePac 12.6.3. TransPax 12.6.4. EnduraCoat 12.6.5. Others 12.7. Europe Drug Eluting Balloon Market Value Share Analysis, By End-use 12.8. Europe Drug Eluting Balloon Market Forecast, By End-use 12.8.1. Hospitals & Ambulatory Surgery Centers 12.8.2. CATH Laboratories 12.8.3. Others 12.9. Europe Drug Eluting Balloon Market Value Share Analysis, by Country 12.10. Europe Drug Eluting Balloon Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Drug Eluting Balloon Market Analysis, by Country 12.12. Germany Drug Eluting Balloon Market Forecast, By Product Type 12.12.1. Coronary Drug Eluting Balloon 12.12.2. Peripheral Drug Eluting Balloon 12.12.3. Others 12.13. Germany Drug Eluting Balloon Market Forecast, By Technology 12.13.1. Paccocath 12.13.2. FreePac 12.13.3. TransPax 12.13.4. EnduraCoat 12.13.5. Others 12.14. Germany Drug Eluting Balloon Market Forecast, By End-use 12.14.1. Hospitals & Ambulatory Surgery Centers 12.14.2. CATH Laboratories 12.14.3. Others 12.15. U.K. Drug Eluting Balloon Market Forecast, By Product Type 12.15.1. Coronary Drug Eluting Balloon 12.15.2. Peripheral Drug Eluting Balloon 12.15.3. Others 12.16. U.K. Drug Eluting Balloon Market Forecast, By Technology 12.16.1. Paccocath 12.16.2. FreePac 12.16.3. TransPax 12.16.4. EnduraCoat 12.16.5. Others 12.17. U.K. Drug Eluting Balloon Market Forecast, By End-use 12.17.1. Hospitals & Ambulatory Surgery Centers 12.17.2. CATH Laboratories 12.17.3. Others 12.18. France Drug Eluting Balloon Market Forecast, By Product Type 12.18.1. Coronary Drug Eluting Balloon 12.18.2. Peripheral Drug Eluting Balloon 12.18.3. Others 12.19. France Drug Eluting Balloon Market Forecast, By Technology 12.19.1. Paccocath 12.19.2. FreePac 12.19.3. TransPax 12.19.4. EnduraCoat 12.19.5. Others 12.20. France Drug Eluting Balloon Market Forecast, By End-use 12.20.1. Hospitals & Ambulatory Surgery Centers 12.20.2. CATH Laboratories 12.20.3. Others 12.21. Italy Drug Eluting Balloon Market Forecast, By Product Type 12.21.1. Coronary Drug Eluting Balloon 12.21.2. Peripheral Drug Eluting Balloon 12.21.3. Others 12.22. Italy Drug Eluting Balloon Market Forecast, By Technology 12.22.1. Paccocath 12.22.2. FreePac 12.22.3. TransPax 12.22.4. EnduraCoat 12.22.5. Others 12.23. Italy Drug Eluting Balloon Market Forecast, By End-use 12.23.1. Hospitals & Ambulatory Surgery Centers 12.23.2. CATH Laboratories 12.23.3. Others 12.24. Spain Drug Eluting Balloon Market Forecast, By Product Type 12.24.1. Coronary Drug Eluting Balloon 12.24.2. Peripheral Drug Eluting Balloon 12.24.3. Others 12.25. Spain Drug Eluting Balloon Market Forecast, By Technology 12.25.1. Paccocath 12.25.2. FreePac 12.25.3. TransPax 12.25.4. EnduraCoat 12.25.5. Others 12.26. Spain Drug Eluting Balloon Market Forecast, By End-use 12.26.1. Hospitals & Ambulatory Surgery Centers 12.26.2. CATH Laboratories 12.26.3. Others 12.27. Rest of Europe Drug Eluting Balloon Market Forecast, By Product Type 12.27.1. Coronary Drug Eluting Balloon 12.27.2. Peripheral Drug Eluting Balloon 12.27.3. Others 12.28. Rest of Europe Drug Eluting Balloon Market Forecast, By Technology 12.28.1. Paccocath 12.28.2. FreePac 12.28.3. TransPax 12.28.4. EnduraCoat 12.28.5. Others 12.29. Rest of Europe Drug Eluting Balloon Market Forecast, By End-use 12.29.1. Hospitals & Ambulatory Surgery Centers 12.29.2. CATH Laboratories 12.29.3. Others 12.30. Europe Drug Eluting Balloon Market Attractiveness Analysis 12.30.1. By Product Type 12.30.2. By Technology 12.30.3. By End-use 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Development 13. Asia Pacific Drug Eluting Balloon Market Analysis 13.1. Key Findings 13.2. Asia Pacific Drug Eluting Balloon Market Overview 13.3. Asia Pacific Drug Eluting Balloon Market Value Share Analysis, By Product Type 13.4. Asia Pacific Drug Eluting Balloon Market Forecast, By Product Type 13.4.1. Coronary Drug Eluting Balloon 13.4.2. Peripheral Drug Eluting Balloon 13.4.3. Others 13.5. Asia Pacific Drug Eluting Balloon Market Value Share Analysis, By Technology 13.6. Asia Pacific Drug Eluting Balloon Market Forecast, By Technology 13.6.1. Paccocath 13.6.2. FreePac 13.6.3. TransPax 13.6.4. EnduraCoat 13.6.5. Others 13.7. Asia Pacific Drug Eluting Balloon Market Value Share Analysis, By End-use 13.8. Asia Pacific Drug Eluting Balloon Market Forecast, By End-use 13.8.1. Hospitals & Ambulatory Surgery Centers 13.8.2. CATH Laboratories 13.8.3. Others 13.9. Asia Pacific Drug Eluting Balloon Market Value Share Analysis, by Country 13.10. Asia Pacific Drug Eluting Balloon Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Drug Eluting Balloon Market Analysis, by Country 13.12. China Drug Eluting Balloon Market Forecast, By Product Type 13.12.1. Coronary Drug Eluting Balloon 13.12.2. Peripheral Drug Eluting Balloon 13.12.3. Others 13.13. China Drug Eluting Balloon Market Forecast, By Technology 13.13.1. Paccocath 13.13.2. FreePac 13.13.3. TransPax 13.13.4. EnduraCoat 13.13.5. Others 13.14. China Drug Eluting Balloon Market Forecast, By End-use 13.14.1. Hospitals & Ambulatory Surgery Centers 13.14.2. CATH Laboratories 13.14.3. Others 13.15. India Drug Eluting Balloon Market Forecast, By Product Type 13.15.1. Coronary Drug Eluting Balloon 13.15.2. Peripheral Drug Eluting Balloon 13.15.3. Others 13.16. India Drug Eluting Balloon Market Forecast, By Technology 13.16.1. Paccocath 13.16.2. FreePac 13.16.3. TransPax 13.16.4. EnduraCoat 13.16.5. Others 13.17. India Drug Eluting Balloon Market Forecast, By End-use 13.17.1. Hospitals & Ambulatory Surgery Centers 13.17.2. CATH Laboratories 13.17.3. Others 13.18. Japan Drug Eluting Balloon Market Forecast, By Product Type 13.18.1. Coronary Drug Eluting Balloon 13.18.2. Peripheral Drug Eluting Balloon 13.18.3. Others 13.19. Japan Drug Eluting Balloon Market Forecast, By Technology 13.19.1. Paccocath 13.19.2. FreePac 13.19.3. TransPax 13.19.4. EnduraCoat 13.19.5. Others 13.20. Japan Drug Eluting Balloon Market Forecast, By End-use 13.20.1. Hospitals & Ambulatory Surgery Centers 13.20.2. CATH Laboratories 13.20.3. Others 13.21. ASEAN Drug Eluting Balloon Market Forecast, By Product Type 13.21.1. Coronary Drug Eluting Balloon 13.21.2. Peripheral Drug Eluting Balloon 13.21.3. Others 13.22. ASEAN Drug Eluting Balloon Market Forecast, By Technology 13.22.1. Paccocath 13.22.2. FreePac 13.22.3. TransPax 13.22.4. EnduraCoat 13.22.5. Others 13.23. ASEAN Drug Eluting Balloon Market Forecast, By End-use 13.23.1. Hospitals & Ambulatory Surgery Centers 13.23.2. CATH Laboratories 13.23.3. Others 13.24. Rest of Asia Pacific Drug Eluting Balloon Market Forecast, By Product Type 13.24.1. Coronary Drug Eluting Balloon 13.24.2. Peripheral Drug Eluting Balloon 13.24.3. Others 13.25. Rest of Asia Pacific Drug Eluting Balloon Market Forecast, By Technology 13.25.1. Paccocath 13.25.2. FreePac 13.25.3. TransPax 13.25.4. EnduraCoat 13.25.5. Others 13.26. Rest of Asia Pacific Drug Eluting Balloon Market Forecast, By End-use 13.26.1. Hospitals & Ambulatory Surgery Centers 13.26.2. CATH Laboratories 13.26.3. Others 13.27. Asia Pacific Drug Eluting Balloon Market Attractiveness Analysis 13.27.1. By Product Type 13.27.2. By Technology 13.27.3. By End-use 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Development 14. Middle East & Africa Drug Eluting Balloon Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Drug Eluting Balloon Market Overview 14.3. Middle East & Africa Drug Eluting Balloon Market Value Share Analysis, By Product Type 14.4. Middle East & Africa Drug Eluting Balloon Market Forecast, By Product Type 14.4.1. Coronary Drug Eluting Balloon 14.4.2. Peripheral Drug Eluting Balloon 14.4.3. Others 14.5. Middle East & Africa Drug Eluting Balloon Market Value Share Analysis, By Technology 14.6. Middle East & Africa Drug Eluting Balloon Market Forecast, By Technology 14.6.1. Paccocath 14.6.2. FreePac 14.6.3. TransPax 14.6.4. EnduraCoat 14.6.5. Others 14.7. Middle East & Africa Drug Eluting Balloon Market Value Share Analysis, By End-use 14.8. Middle East & Africa Drug Eluting Balloon Market Forecast, By End-use 14.8.1. Hospitals & Ambulatory Surgery Centers 14.8.2. CATH Laboratories 14.8.3. Others 14.9. Middle East & Africa Drug Eluting Balloon Market Value Share Analysis, by Country 14.10. Middle East & Africa Drug Eluting Balloon Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Drug Eluting Balloon Market Analysis, by Country 14.12. GCC Drug Eluting Balloon Market Forecast, By Product Type 14.12.1. Coronary Drug Eluting Balloon 14.12.2. Peripheral Drug Eluting Balloon 14.12.3. Others 14.13. GCC Drug Eluting Balloon Market Forecast, By Technology 14.13.1. Paccocath 14.13.2. FreePac 14.13.3. TransPax 14.13.4. EnduraCoat 14.13.5. Others 14.14. GCC Drug Eluting Balloon Market Forecast, By End-use 14.14.1. Hospitals & Ambulatory Surgery Centers 14.14.2. CATH Laboratories 14.14.3. Others 14.15. South Africa Drug Eluting Balloon Market Forecast, By Product Type 14.15.1. Coronary Drug Eluting Balloon 14.15.2. Peripheral Drug Eluting Balloon 14.15.3. Others 14.16. South Africa Drug Eluting Balloon Market Forecast, By Technology 14.16.1. Paccocath 14.16.2. FreePac 14.16.3. TransPax 14.16.4. EnduraCoat 14.16.5. Others 14.17. South Africa Drug Eluting Balloon Market Forecast, By End-use 14.17.1. Hospitals & Ambulatory Surgery Centers 14.17.2. CATH Laboratories 14.17.3. Others 14.18. Rest of Middle East & Africa Drug Eluting Balloon Market Forecast, By Product Type 14.18.1. Coronary Drug Eluting Balloon 14.18.2. Peripheral Drug Eluting Balloon 14.18.3. Others 14.19. Rest of Middle East & Africa Drug Eluting Balloon Market Forecast, By Technology 14.19.1. Paccocath 14.19.2. FreePac 14.19.3. TransPax 14.19.4. EnduraCoat 14.19.5. Others 14.20. Rest of Middle East & Africa Drug Eluting Balloon Market Forecast, By End-use 14.20.1. Hospitals & Ambulatory Surgery Centers 14.20.2. CATH Laboratories 14.20.3. Others 14.21. Middle East & Africa Drug Eluting Balloon Market Attractiveness Analysis 14.21.1. By Product Type 14.21.2. By Technology 14.21.3. By End-use 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Development 15. South America Drug Eluting Balloon Market Analysis 15.1. Key Findings 15.2. South America Drug Eluting Balloon Market Overview 15.3. South America Drug Eluting Balloon Market Value Share Analysis, By Product Type 15.4. South America Drug Eluting Balloon Market Forecast, By Product Type 15.4.1. Coronary Drug Eluting Balloon 15.4.2. Peripheral Drug Eluting Balloon 15.4.3. Others 15.5. South America Drug Eluting Balloon Market Value Share Analysis, By Technology 15.6. South America Drug Eluting Balloon Market Forecast, By Technology 15.6.1. Paccocath 15.6.2. FreePac 15.6.3. TransPax 15.6.4. EnduraCoat 15.6.5. Others 15.7. South America Drug Eluting Balloon Market Value Share Analysis, By End-use 15.8. South America Drug Eluting Balloon Market Forecast, By End-use 15.8.1. Hospitals & Ambulatory Surgery Centers 15.8.2. CATH Laboratories 15.8.3. Others 15.9. South America Drug Eluting Balloon Market Value Share Analysis, by Country 15.10. South America Drug Eluting Balloon Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Drug Eluting Balloon Market Analysis, by Country 15.12. Brazil Drug Eluting Balloon Market Forecast, By Product Type 15.12.1. Coronary Drug Eluting Balloon 15.12.2. Peripheral Drug Eluting Balloon 15.12.3. Others 15.13. Brazil Drug Eluting Balloon Market Forecast, By Technology 15.13.1. Paccocath 15.13.2. FreePac 15.13.3. TransPax 15.13.4. EnduraCoat 15.13.5. Others 15.14. Brazil Drug Eluting Balloon Market Forecast, By End-use 15.14.1. Hospitals & Ambulatory Surgery Centers 15.14.2. CATH Laboratories 15.14.3. Others 15.15. Mexico Drug Eluting Balloon Market Forecast, By Product Type 15.15.1. Coronary Drug Eluting Balloon 15.15.2. Peripheral Drug Eluting Balloon 15.15.3. Others 15.16. Mexico Drug Eluting Balloon Market Forecast, By Technology 15.16.1. Paccocath 15.16.2. FreePac 15.16.3. TransPax 15.16.4. EnduraCoat 15.16.5. Others 15.17. Mexico Drug Eluting Balloon Market Forecast, By End-use 15.17.1. Hospitals & Ambulatory Surgery Centers 15.17.2. CATH Laboratories 15.17.3. Others 15.18. Rest of South America Drug Eluting Balloon Market Forecast, By Product Type 15.18.1. Coronary Drug Eluting Balloon 15.18.2. Peripheral Drug Eluting Balloon 15.18.3. Others 15.19. Rest of South America Drug Eluting Balloon Market Forecast, By Technology 15.19.1. Paccocath 15.19.2. FreePac 15.19.3. TransPax 15.19.4. EnduraCoat 15.19.5. Others 15.20. Rest of South America Drug Eluting Balloon Market Forecast, By End-use 15.20.1. Hospitals & Ambulatory Surgery Centers 15.20.2. CATH Laboratories 15.20.3. Others 15.21. South America Drug Eluting Balloon Market Attractiveness Analysis 15.21.1. By Product Type 15.21.2. By Technology 15.21.3. By End-use 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Development 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Medtronic, Inc. 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Company Footprint 16.3.2. Becton, Dickinson and Company 16.3.3. Boston Scientific Corporation 16.3.4. Cook Medical Incorporated 16.3.5. Braun Melsungen AG 16.3.6. Koninklijke Philips N.V. 16.3.7. Opto Circuits (India) Limited 16.3.8. Terumo Corporation 16.3.9. Surmodics, Inc. 16.3.10. Biotronik, Inc. 16.3.11. Concept Medical Inc. 16.3.12. BIOTRONIK SE & Co. KG 16.3.13. Innvolution Healthcare Pvt. Ltd. 16.3.14. Medtronic plc 16.3.15. Eurocor GmbH 16.3.16. C.R. Bard 16.3.17. Aachen Resonance GmbH 17. Primary Key Insights

About This Report

Report ID40237
Category Healthcare
Published DateDec 2019
Updated DateNov 2020
Contact Us